Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
Scientific Reports|July 19, 2026
Combined impact of recent sexual activity and vaginal product use on genital immune activation in South African women: implications for HIV riskSamukelisiwe Radebe, Phumla Radebe, Zanenhlanhla Gumbi, et al.
Frontiers in Immunology|October 1, 2021
Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial VaginosisAndile Mtshali, James Emmanuel San, Farzana Osman, et al.
Medrxiv : the Preprint Server for Health Sciences|September 29, 2025
Rapid loss of activity but not serum concentration in a passive infusion clinical trial of an HIV neutralizing antibodySharana Mahomed, Nonhlanhla N Mkhize, Leonid A Serebryannyy, et al.
JAMA Network Open|November 2, 2019
Trends in HIV Prevention, Treatment, and Incidence in a Hyperendemic Area of KwaZulu-Natal, South AfricaAyesha B M Kharsany, Cherie Cawood, Lara Lewis, et al.
Nature Medicine|October 23, 2012
Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escapePenny L Moore, Elin S Gray, C Kurt Wibmer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 23, 2015
Genital inflammation and the risk of HIV acquisition in womenLindi Masson, Jo-Ann S Passmore, Lenine J Liebenberg, et al.
The Lancet. HIV|March 31, 2023
Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trialSharana Mahomed, Nigel Garrett, Edmund V Capparelli, et al.
The Journal of Infectious Diseases|February 8, 2022
Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus PreventionSharana Mahomed, Nigel Garrett, Edmund V Capparelli, et al.
The Lancet. HIV|March 10, 2022
Kidney function in tenofovir disoproxil fumarate-based oral pre-exposure prophylaxis users: a systematic review and meta-analysis of published literature and a multi-country meta-analysis of individual participant dataRobin Schaefer, Pedro Henrique Amparo da Costa Leite, Ronaldo Silva, et al.
Sexually Transmitted Infections|December 4, 2024
Differences in HIV risk factors between South African adolescents and adult women and their association with sexually transmitted infectionsPamela Mkhize, Celia Mehou-Loko, Nokuthula Maphumulo, et al.
Pageof 21